Research Article
Capillary Dilation and Rarefaction Are Correlated with Intracapillary Inflammation in Antibody-Mediated Rejection
Table 1
Clinical characteristics of patients who participated in this study.
| | Characteristics | ABMR () | TCMR () | SG () | value |
| | Gender, male (%) | 9 (50.00) | 10 (76.92) | 10 (71.42) | 0.244 | | Age (years) | | | | 0.393 | | Donor age (years) | | | | 0.349 | | Positive pretransplant PRA () | 0 | 0 | 0 | — | | Previous transplant | 0 | 0 | 0 | — | | Previous rejection, (%) | 0 | 0 | 0 | — | | Cold ischemic time (h) | | | | 0.471 | | Warm ischemic time (min) | | | | 0.728 | | Induction with IL-2R antibody, (%) | 18 (100) | 13 (100) | 14 (100) | — | | Baseline immunosuppressants | | | | 0.224 | | MMF + Tac + Pred | 13 | 10 | 8 | | | MMF + CsA + Pred | 5 | 3 | 3 | | | Others | 0 | 0 | 3 | | | Time of biopsy (day) | 8 (5–20) | 15 (11–25) | 14 (12–15) | 0.14 |
|
|
Abbreviations: ABMR: antibody-mediated rejection; TCMR: T cell-mediated rejection; SG: stable graft; PRA: panel-reactive antibody; IL: interleukin; MMF: mycophenolate mofetil; Pred: prednisolone; Tac: tacrolimus; CsA: cyclosporine A.
|
